Morrow Phuong Khanh 4
4 · CRISPR Therapeutics AG · Filed Oct 17, 2023
Insider Transaction Report
Form 4
Morrow Phuong Khanh
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-10-13+16,667→ 16,667 totalExercise: $44.31Exp: 2033-10-13→ Common Shares (16,667 underlying)
Footnotes (1)
- [F1]This option was granted on October 13, 2023 with respect to 16,667 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of November 13, 2023.